SpectraCure Competitors and Similar CompaniesClear all
SpectraCure's competitors and similar companies include Ardelyx.
 Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. | ||
Founding Date | Founding Date 2003 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations HQ | Locations Fremont, US HQ Waltham, US Waltham, US |
Employees | Employees N/A | Employees 882% increase |
Valuation ($) | Valuation ($) 16.2 m | Valuation ($) 1.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $407.3m (FY, 2025) |
Cost of goods | Cost of goods kr7.2m (FY, 2025) | Cost of goods $39.5m (FY, 2025) |
Gross profit | Gross profit (kr6.3m) (FY, 2025) | Gross profit $367.8m (FY, 2025) |
Net income | Net income (kr56.1m) (FY, 2025) | Net income ($61.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Ardelyx
HQ
Fremont, US
Employees
88↑ 2% increase
Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
View company